NuCana plc (NCNA) Financials

NCNA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 36.4 million 6.8 million
Dec. 31, 2025 40.0 million 7.4 million
Sept. 30, 2025 43.4 million 8.6 million
June 30, 2025 22.3 million 12.1 million

NCNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.2 million 2.5 million
Dec. 31, 2025 -1.2 million 1.2 million
Sept. 30, 2025 1.7 million 1.2 million
June 30, 2025 -6.2 million 11.0 million

NCNA Net Income

No data available :(

NCNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 28.4 million - 854126
Dec. 31, 2025 32.5 million - 906868
Sept. 30, 2025 33.9 million - 182823
June 30, 2025 11.6 million - 211436

NCNA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 4.9 million
Dec. 31, 2025 5.0 million
Sept. 30, 2025 5.0 million
June 30, 2025 8.3 million

NCNA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.1 million 5.7 million 2.7 million -
Dec. 31, 2025 67190 2.3 million 1.5 million -
Sept. 30, 2025 63181 2.9 million 1.9 million -
June 30, 2025 78259 9.8 million 6.2 million -

NCNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 120947
Dec. 31, 2025 - 91516
Sept. 30, 2025 - -
June 30, 2025 - -

NCNA

Price: $1.95

52 week price:
1.33
40.00

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 46300

Market Capitalization: 11.8 million

Links: